Researcher Profile

Keywords Cloud

KRIBB Co-Working

Results 1-20 of 92 (Search time: 0.003 seconds).

No. Year Title Type
92 2022

2022Patent

아커만시아 뮤시니필라 균주 또는 이의 배양물을 유효성분으로 함유하는 노화방지용 조성물KR10-2022-0004861 (2022.01.12) / 10-2467815 (2022.11.11)김경심정해용황정환김병찬김용훈; 김재훈; 노정란장동호최영근이철호, et al.
Patent
91 2022

2022Patent

아커만시아 뮤시니필라 균주 또는 이의 배양물을 유효성분으로 함유하는 노화방지용 조성물KR10-2019-0114826 (2019.09.18) / 10-2377407 (2022.03.17)김경심정해용황정환김병찬김용훈; 김재훈; 노정란장동호최영근이철호, et al.
Patent
90 2022

2022Article

Synaptotagmin 11 scaffolds MKK7-JNK signaling process to promote stem-like molecular subtype gastric cancer oncogenesisJournal of Experimental & Clinical Cancer Research, vol. 41, pp. 212-212Bo Kyung Kim; Da Mi Kim; Hyunkyung Park; Seon-Kyu Kim; Mi Aie Hwang; Jungwoon LeeMi-Jung Kang; Jae Eun Byun; Joo-Young ImMinho Kang, et al.
Article
89 2022

2022Article

SARS-CoV-2 peptides bind to NKG2D and increase NK cell activityCellular Immunology, vol. 371, pp. 104454-104454Hanna Kim; Byun Jae Eun; Suk Ran Yoon; H Koohy; Haiyoung Jung; In Pyo Choi
Article
88 2022

2022Article

Root extract of a micropropagated Prunus africana medicinal plant induced apoptosis in human prostate cancer cells (PC-3) via caspase-3 activationEvidence-Based Complementary and Alternative Medicine, vol. 2022, pp. 8232851-8232851R Komakech; N H Yim; K S Shin; Haiyoung Jung; Jae Eun Byun; J Lee; D Okello; M G Matsabisa; J O Erhabor; O Oyenihi, et al.
Article
87 2022

2022Article

Ginsenoside 20(R)-Rg3 enhances natural killer cell activity by increasing activating receptor expression through the MAPK/ERK signaling pathwayInternational Immunopharmacology, vol. 107, pp. 108618-108618Yunhee Lee; Arum Park; Young-Jun ParkHaiyoung JungTae-Don KimJi Yoon Noh; In Pyo Choi; S Lee; Suk Ran Yoon
Article
86 2022

2022Research Project

항암 면역세포 치료기술 개발 = Developemnt of anti-cancer immunotherapy연구책임자 : 윤석란 / 사업기간 : 2022.01.01 ~ 2022.12.31
Research Project
85 2022

2022Research Project

조혈줄기세포 운명결정 인자 WIP1의 NK 세포 분화 및 활성 조절 연구 = Regulation of natural killer cell development and cytotoxicity by hematopoietic stem cell fate determining factor WIP1연구책임자 : 정해용 / 사업기간 : 2022.03.01 ~ 2023.02.28
Research Project
84 2022

2022Article

Aurantii Fructus Immaturus enhances natural killer cytolytic activity and anticancer efficacy in vitro and in vivoFrontiers in Medicine, vol. 9, pp. 973681-973681Arum Park; Yunjeong Yang; Yunhee Lee; Haiyoung JungTae-Don KimJi Yoon Noh; S Lee; Suk Ran Yoon
Article
83 2022

2022Research Project

단백질 분해 기반 신약개발 플랫폼 기술 개발 = Development of drug discovery platform based on targeted protein degradation연구책임자 : 김정훈 / 사업기간 : 2022.01.01 ~ 2022.12.31
Research Project
82 2022

2022Research Project

In silico 기반 조혈줄기세포 역노화 기술 개발연구책임자 : 정해용 / 사업기간 : 2022.05.01 ~ 2023.04.30
Research Project
81 2021

2021Article

Collapsin response mediator protein 4 enhances the radiosensitivity of colon cancer cells through calcium-mediated cell signalingOncology Reports, vol. 45, no. 4, pp. 6-6Sang Yoon Park; Jong-Tae Kim; Eun Sun Park; Yo Sep Hwang; Hyang Ran Yoon; Kyung Eun Baek; Haiyoung JungSuk Ran YoonBo Yeon KimHee Jun Cho, et al.
Article
80 2021

2021Article

Emerging approaches for solid tumor treatment using CAR-T cell therapyInternational Journal of Molecular Sciences, vol. 22, no. 22, pp. 12126-12126Hyunmin Chung; Haiyoung JungJi Yoon Noh
Article
79 2021

2021Article

Ageing and rejuvenation models reveal changes in key microbial communities associated with healthy ageingMicrobiome, vol. 9, pp. 240-240J Shin; Jung Ran Noh; D Choe; N Lee; Y Song; S Cho; Eun Jung Kang; Min-Jeong Go; Seok-Kyun Ha; Dong-Ho Chang, et al.
Article
78 2021

2021Research Project

항암 면역세포 치료기술 개발 = Developemnt of anti-cancer immunotherapy연구책임자 : 윤석란 / 사업기간 : 2021.01.01 ~ 2021.12.31
Research Project
77 2021

2021Research Project

조혈줄기세포 운명결정 인자 WIP1의 NK 세포 분화 및 활성 조절 연구 = Regulation of natural killer cell development and cytotoxicity by hematopoietic stem cell fate determining factor WIP1연구책임자 : 정해용 / 사업기간 : 2021.03.01 ~ 2022.02.28
Research Project
76 2021

2021Research Project

NK세포 치료제 개발 = Development of NK cell therapy연구책임자 : 윤석란 / 사업기간 : 2021.07.01 ~ 2022.06.30
Research Project
75 2020

2020Article

A three-dimensional hyaluronic acid-based niche enhances the therapeutic efficacy of human natural killer cell-based cancer immunotherapyBiomaterials, vol. 247, pp. 119960-119960Young Ha Ahn; L Ren; Seok Min Kim; Sang-Hwan Seo; Cho Rok Jung; Da-Seul Kim; Ji Yoon NohSoo Yun Lee; H Lee; M Y Cho, et al.
Article
74 2020

2020Article

Toll-like receptors in natural killer cells and their application for immunotherapyJournal of Immunology Research, vol. 2020, pp. 2045860-2045860Ji Yoon NohSuk Ran YoonTae-Don Kim; In Pyo Choi; Haiyoung Jung
Article
73 2020

2020Article

The Gata1low murine megakaryocyte-erythroid progenitor cells expand robustly and alter differentiation potentialBiochemical and Biophysical Research Communications, vol. 528, pp. 46-53Eunju Shin; Jong Gwan Jeong; Hyunmin Chung; Haiyoung Jung; C Park; Suk Ran YoonTae-Don Kim; S J Lee; Inpyo Choi; Ji Yoon Noh
Article
1 2 3 4 5